To Determine the Effect of CYP Induction Following Administration of Nirogacestat in Healthy Adult Male Participants
Clinical trial NCT07259330 · COMPLETED
Trial details
- NCT number
- NCT07259330
- Sponsor
- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-27
- Primary completion
- 2026-03-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.